Home/Filings/4/0001793373-23-000005
4//SEC Filing

STROME MARK E 4

Accession 0001793373-23-000005

CIK 0001101026other

Filed

Oct 29, 8:00 PM ET

Accepted

Oct 30, 5:01 PM ET

Size

35.5 KB

Accession

0001793373-23-000005

Insider Transaction Report

Form 4
Period: 2021-06-02
STROME MARK E
10% Owner
Transactions
  • Conversion

    Common Stock

    2021-06-02$8.00/sh+326,286$2,610,288326,286 total(indirect: By entity)
  • Purchase

    Common Stock Purchase Warrant

    2021-06-02$0.01/sh+40,000$40040,000 total(indirect: By Trust)
    Exercise: $5.50From: 2021-06-02Exp: 2026-06-02Common Stock (40,000 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-20208,3330 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (208,333 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-208,3330 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (8,333 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-203,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (3,125 underlying)
  • Purchase

    Common Stock

    2021-06-02$4.99/sh+40,000$199,600203,601 total(indirect: By Trust)
  • Conversion

    Convertible Debt

    2021-06-022,191,1870 total(indirect: By entity)
    Exercise: $8.00Common Stock (326,286 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-09-253,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-09-25Exp: 2022-09-25Common Stock (3,125 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-204,1660 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (4,166 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-07-243,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-07-24Exp: 2022-07-24Common Stock (3,125 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-20104,1660 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (104,166 underlying)
Transactions
  • Conversion

    Common Stock

    2021-06-02$8.00/sh+326,286$2,610,288326,286 total(indirect: By entity)
  • Purchase

    Common Stock Purchase Warrant

    2021-06-02$0.01/sh+40,000$40040,000 total(indirect: By Trust)
    Exercise: $5.50From: 2021-06-02Exp: 2026-06-02Common Stock (40,000 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-07-243,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-07-24Exp: 2022-07-24Common Stock (3,125 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-208,3330 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (8,333 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-09-253,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-09-25Exp: 2022-09-25Common Stock (3,125 underlying)
  • Purchase

    Common Stock

    2021-06-02$4.99/sh+40,000$199,600203,601 total(indirect: By Trust)
  • Conversion

    Convertible Debt

    2021-06-022,191,1870 total(indirect: By entity)
    Exercise: $8.00Common Stock (326,286 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-20208,3330 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (208,333 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-203,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (3,125 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-20104,1660 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (104,166 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-204,1660 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (4,166 underlying)
Transactions
  • Purchase

    Common Stock

    2021-06-02$4.99/sh+40,000$199,600203,601 total(indirect: By Trust)
  • Conversion

    Convertible Debt

    2021-06-022,191,1870 total(indirect: By entity)
    Exercise: $8.00Common Stock (326,286 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-09-253,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-09-25Exp: 2022-09-25Common Stock (3,125 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-203,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (3,125 underlying)
  • Conversion

    Common Stock

    2021-06-02$8.00/sh+326,286$2,610,288326,286 total(indirect: By entity)
  • Purchase

    Common Stock Purchase Warrant

    2021-06-02$0.01/sh+40,000$40040,000 total(indirect: By Trust)
    Exercise: $5.50From: 2021-06-02Exp: 2026-06-02Common Stock (40,000 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-07-243,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-07-24Exp: 2022-07-24Common Stock (3,125 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-20208,3330 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (208,333 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-20104,1660 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (104,166 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-204,1660 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (4,166 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-208,3330 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (8,333 underlying)
Transactions
  • Conversion

    Convertible Debt

    2021-06-022,191,1870 total(indirect: By entity)
    Exercise: $8.00Common Stock (326,286 underlying)
  • Purchase

    Common Stock

    2021-06-02$4.99/sh+40,000$199,600203,601 total(indirect: By Trust)
  • Other

    Common Stock Purchase Warrant

    2022-09-253,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-09-25Exp: 2022-09-25Common Stock (3,125 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-203,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (3,125 underlying)
  • Conversion

    Common Stock

    2021-06-02$8.00/sh+326,286$2,610,288326,286 total(indirect: By entity)
  • Purchase

    Common Stock Purchase Warrant

    2021-06-02$0.01/sh+40,000$40040,000 total(indirect: By Trust)
    Exercise: $5.50From: 2021-06-02Exp: 2026-06-02Common Stock (40,000 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-20208,3330 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (208,333 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-208,3330 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (8,333 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-204,1660 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (4,166 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-07-243,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-07-24Exp: 2022-07-24Common Stock (3,125 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-20104,1660 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (104,166 underlying)
Transactions
  • Purchase

    Common Stock Purchase Warrant

    2021-06-02$0.01/sh+40,000$40040,000 total(indirect: By Trust)
    Exercise: $5.50From: 2021-06-02Exp: 2026-06-02Common Stock (40,000 underlying)
  • Conversion

    Convertible Debt

    2021-06-022,191,1870 total(indirect: By entity)
    Exercise: $8.00Common Stock (326,286 underlying)
  • Conversion

    Common Stock

    2021-06-02$8.00/sh+326,286$2,610,288326,286 total(indirect: By entity)
  • Other

    Common Stock Purchase Warrant

    2022-07-243,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-07-24Exp: 2022-07-24Common Stock (3,125 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-208,3330 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (8,333 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-204,1660 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (4,166 underlying)
  • Purchase

    Common Stock

    2021-06-02$4.99/sh+40,000$199,600203,601 total(indirect: By Trust)
  • Other

    Common Stock Purchase Warrant

    2022-09-253,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-09-25Exp: 2022-09-25Common Stock (3,125 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-203,1250 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (3,125 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-20104,1660 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (104,166 underlying)
  • Other

    Common Stock Purchase Warrant

    2022-11-20208,3330 total(indirect: By entity)
    Exercise: $8.00From: 2017-11-20Exp: 2022-11-20Common Stock (208,333 underlying)
Footnotes (5)
  • [F1]The reported transaction resulted from the conversion of convertible debt into shares of common stock at $8.00.
  • [F2]This filing is made on behalf of Strome Mezzanine Fund, L.P ("Strome Mezzanine"), Strome Alpha Fund LP ("Strome Alpha"), Strome Investment Management, LP, Strome Group, Inc., and Mark Strome (together, the "Reporting Persons"). Strome Investment Management, LP is the general partner of Strome Mezzanine. Strome Group, Inc. is the general partner of Strome Investment Management, LP. Mark Strome is the President and CEO of Strome Group, Inc. Strome Investment Management, LP, Strome Group, Inc., and Mark Strome may be deemed to share voting and investment power for the shares held by Strome Mezzanine and Strome Alpha.
  • [F3]Pursuant to Rule 16a-1(a)(4) of the Securities Exchange Act of 1934 (the "Exchange Act"), this filing shall not be deemed an admission that the Reporting Persons are, for purposes of Section 16 of the Exchange Act or otherwise, the beneficial owner of any equity securities reported herein.
  • [F4]The convertible debt was convertible at any time prior to, and did not expire until, the repayment or conversion of the convertible debt in full.
  • [F5]Expiration of long derivative position (warrant) without value received.

Issuer

Zivo Bioscience, Inc.

CIK 0001101026

Entity typeother

Related Parties

1
  • filerCIK 0000919484

Filing Metadata

Form type
4
Filed
Oct 29, 8:00 PM ET
Accepted
Oct 30, 5:01 PM ET
Size
35.5 KB